Not Rated
|
Fund Size
(0.01% of Investment in Category)
|
Expense Ratio
(0.52% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 04-Nov-25 | 10190.40 | 1.90% | - | 1.48% | 135/729 |
| 1 Month | 10-Oct-25 | 10218.50 | 2.19% | - | 1.71% | 310/724 |
| 3 Month | 12-Aug-25 | 10682.70 | 6.83% | - | 5.91% | 388/705 |
| 6 Month | 12-May-25 | 11056.70 | 10.57% | - | 8.60% | 94/665 |
| YTD | 31-Dec-24 | 10428.50 | 4.29% | - | 10.23% | 459/608 |
| 1 Year | 12-Nov-24 | 10686.90 | 6.87% | 6.87% | 12.12% | 318/582 |
| 2 Year | 10-Nov-23 | 14585.50 | 45.86% | 20.68% | 17.29% | 114/455 |
| 3 Year | 11-Nov-22 | 16790.80 | 67.91% | 18.82% | 16.72% | 102/348 |
| 5 Year | 12-Nov-20 | 20088.30 | 100.88% | 14.96% | 18.47% | 156/177 |
| Since Inception | 26-Oct-20 | 20686.10 | 106.86% | 15.48% | 12.22% | 202/771 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 12-Nov-24 | 13000 | 13910.79 | 7.01 % | 14.22 % |
| 2 Year | 10-Nov-23 | 25000 | 28368.22 | 13.47 % | 13.11 % |
| 3 Year | 11-Nov-22 | 37000 | 47860.69 | 29.35 % | 17.82 % |
| 5 Year | 12-Nov-20 | 61000 | 89741.84 | 47.12 % | 15.62 % |
Please check with your Tax Advisor.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 187.4 | 11.16% | 0.27% | 13.13% (Nov 2024) | 10.84% (Aug 2025) | 1.11 L | -0.31 k |
| Max Healthcare Institute Ltd. | Hospital | 103.1 | 6.14% | -0.03% | 7.08% (Jun 2025) | 5.85% (Nov 2024) | 89.81 k | -0.25 k |
| Cipla Ltd. | Pharmaceuticals | 98 | 5.84% | -0.21% | 6.36% (Aug 2025) | 5.7% (Dec 2024) | 65.30 k | -0.18 k |
| ELI LILLY ORD SHS | Foreign equity | 96.5 | 5.75% | 0.50% | 6.34% (Feb 2025) | 4.86% (May 2025) | 1.26 k | 0.00 |
| Divis Laboratories Ltd. | Pharmaceuticals | 93 | 5.54% | 0.70% | 6.03% (May 2025) | 4.84% (Sep 2025) | 13.80 k | -38.00 |
| Apollo Hospitals Enterprises Ltd. | Hospital | 89.3 | 5.32% | 0.01% | 5.43% (Aug 2025) | 4.75% (Feb 2025) | 11.62 k | -32.00 |
| Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 80.8 | 4.81% | -0.28% | 5.76% (Dec 2024) | 4.81% (Oct 2025) | 67.46 k | -0.19 k |
| Johnson & Johnson | Foreign equity | 63 | 3.75% | -0.05% | 3.8% (Sep 2025) | 2.84% (Dec 2024) | 3.76 k | 0.00 |
| Fortis Healthcare Ltd. | Hospital | 58 | 3.45% | 0.06% | 3.45% (Oct 2025) | 2.32% (Jan 2025) | 56.67 k | -0.16 k |
| AbbVie Inc | Foreign equity | 53.4 | 3.18% | -0.31% | 3.49% (Sep 2025) | 2.49% (Nov 2024) | 2.76 k | 0.00 |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 0.15% |
| Net Receivables | Net Receivables | 0.00% |
Ratios calculated on daily returns for last 3 years (Updated as on 31st October, 2025)
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| ICICI Prudential Silver ETF | NA | 9445.03 | -4.17 | 41.21 | 67.16 | 79.75 | 36.17 |
| Aditya Birla Sun Life Silver ETF | NA | 1756.21 | -4.17 | 41.10 | 67.04 | 79.69 | 36.20 |
| DSP Silver ETF | NA | 1374.63 | -4.08 | 41.21 | 67.11 | 79.65 | 36.43 |
| Mirae Asset Silver ETF | NA | 460.88 | -4.14 | 41.09 | 66.96 | 79.53 | 0.00 |
| Axis Silver ETF | NA | 720.88 | -4.17 | 41.01 | 66.90 | 79.51 | 36.02 |
| HDFC Silver ETF | NA | 3177.76 | -4.17 | 41.09 | 66.93 | 79.50 | 36.00 |
| Kotak Silver ETF | NA | 2305.14 | -4.19 | 41.09 | 66.92 | 79.46 | 0.00 |
| SBI Silver ETF | NA | 2330.68 | -4.16 | 41.01 | 66.78 | 79.26 | 0.00 |
| Nippon India Silver ETF | NA | 17525.28 | -4.18 | 41.01 | 66.79 | 79.12 | 36.28 |
| Edelweiss Silver ETF | NA | 567.57 | -4.17 | 40.95 | 66.72 | 79.07 | 0.00 |
Out of 93 mutual fund schemes offered by this AMC, 1 is/are ranked 5 * , 4 is/are ranked 4 * , 7 is/are ranked 3 * , 4 is/are ranked 2 * , and 77 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| BHARAT Bond ETF - April 2030 | NA | 25397.21 | 0.70 | 2.09 | 3.60 | 9.13 | 8.58 |
| BHARAT Bond ETF - April 2030 | NA | 25397.21 | 0.67 | 1.92 | 3.41 | 8.74 | 8.42 |
| Edelweiss Arbitrage Fund - Growth | 3 | 16687.08 | 0.56 | 1.43 | 2.89 | 6.42 | 7.14 |
| BHARAT Bond ETF - April 2031 | NA | 13413.36 | 0.59 | 1.84 | 3.44 | 8.84 | 8.61 |
| BHARAT Bond ETF - April 2031 | NA | 13413.36 | 0.69 | 2.01 | 3.09 | 8.59 | 8.48 |
| Edelweiss Balanced Advantage Fund - Growth | 2 | 13238.71 | 1.52 | 4.13 | 5.43 | 7.56 | 12.23 |
| Edelweiss Mid Cap Fund - Regular Plan - Growth | 5 | 12646.93 | 1.92 | 4.46 | 9.01 | 9.87 | 24.64 |
| BHARAT Bond ETF - April 2032 | NA | 10800.56 | 0.57 | 2.01 | 3.21 | 8.70 | 8.79 |
| BHARAT Bond ETF - April 2032 | NA | 10800.56 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Edelweiss Liquid Fund - Regular Plan - Growth | 4 | 10620.71 | 0.49 | 1.46 | 3.02 | 6.68 | 6.93 |